Latest Breaking News On - Affamed therapeutics - Page 2 : comparemela.com

Mineralys Therapeutics Appoints Minji Kim, Ph.D. as Chief Business Officer

RADNOR, Pa., Jan. 04, 2024 (GLOBE NEWSWIRE) Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused o.

South koreaSoult ukpyolsiUnited statesMinji kimTom weibleCatalys pacificTanabe pharmaJon congletonAdam levyMineralys therapeutics incBusiness development at curis incExchange commissionGlobal oncology business developmentHead of business developmentElixir health public relationsAlliance management at jounce therapeutics

Mineralys Therapeutics Appoints Minji Kim, Ph.D. As Chief Business Officer

Mineralys Therapeutics Appoints Minji Kim, Ph.D. As Chief Business Officer
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

South koreaUnited statesSoult ukpyolsiAdam levyCatalys pacificTanabe pharmaJon congletonMinji kimTom weibleExchange commissionHarvard medical schoolMineralys therapeutics incSeoul national universityAlliance management at jounce therapeuticsElixir health public relationsHead of business development

The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit Delivered Insights on the Future of Healthcare

The 2023 Asia Health and Life Sciences Innovation and Cooperation Summit Delivered Insights on the Future of Healthcare
aap.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aap.com.au Daily Mail and Mail on Sunday newspapers.

South koreaSoult ukpyolsiChang liuNational university of singaporeSingapore generalRussell reynoldsAnand jhaSino innovax biotecKrishna reddy nallamallaLuming dengSylvia varelaNavjeewan khoslaDiah satyani saminarsihHillgene biopharmaShyam bishenAntonio estrella

AffaMed Therapeutics Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA® in Patients after Cataract Surgery

SHANGHAI, Oct. 31, 2023 /PRNewswire/ AffaMed Therapeutics ("AffaMed"), a global biotechnology company dedicated to developing and commercializing

South koreaDayao zhaoOcular therapeutix incAffamed therapeuticsReal world studyBoao lecheng pilot zoneOcular therapeutixGreater chinaAmed therapeutics

Ocular Therapeutix (OCUL) Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Patients after Cataract Surgery

Ocular Therapeutix (OCUL) Announced Positive Top-Line Results from Real-World Study in China Evaluating the Safety and Efficacy of DEXTENZA in Patients after Cataract Surgery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

South koreaDayao zhaoOcular therapeutix incAffamed therapeuticsReal world studyLecheng pilot zoneOcular therapeutix